| Metric | Value ($ M) | Q1 FY25 |
|---|---|---|
| Revenue | 3.4K | 6.0% |
| Total Income | 3.4K | 6.0% |
| Expenditure | 2.9K | 5.3% |
| PBT | 341.23 | 19.2% |
| Net Profit | 197.53 | 21.2% |
| OPM | 14.11% | 0.49pp |
| NPM | 5.78% | 0.73pp |
| EPS | 2.93 | 42.9% |
DaVita Inc. Reports Q1 2026 Results: Revenue $3.416 Billion
06 May 2026 · 6 May, 1:44 am
Summary
DaVita Inc. announced its financial results for the quarter ended March 31, 2026, with consolidated revenues reaching $3.416 billion. The company reported an operating income of $482 million and diluted earnings per share from continuing operations of $2.87. Operating cash flow was $321 million, and free cash flow amounted to $140 million. During the quarter, DaVita repurchased 3.0 million shares of its common stock. The company provided dialysis services to approximately 296,300 patients at 3,262 outpatient dialysis centers as of March 31, 2026.
Key Highlights
- 1
DaVita Inc. reported consolidated revenues of $3.416 billion for the first quarter of 2026.
- 2
Operating income for the quarter was $482 million.
- 3
Diluted earnings per share from continuing operations reached $2.87.
- 4
The company generated $321 million in operating cash flow and $140 million in free cash flow.
- 5
DaVita repurchased 3.0 million shares of its common stock at an average price of $133.70 per share during the quarter.
- 6
Total U.S. dialysis treatments for the first quarter of 2026 were 7,029,525, averaging 91,650 treatments per day.
Management Comments
Javier Rodriguez
DaVita’s foundation is clinical excellence, driven by operating rigor that produces durable results. We have consistently delivered exceptional clinical outcomes and strong financial performance, and this quarter is no exception.
Informational and educational content only. Not investment advice.